Tobacco Lab: Science and Silence

When the smoking wars heated up, Philip Morris put Victor DeNoble’s nicotine experiments on ice. His story is part of the wider drama involving the industry and its researchers.

It wasn’t like entering the Peace Corps, but Victor DeNoble hoped to do some good when he joined the tobacco industry.

The year was 1980 and DeNoble, then a 30-year-old Ph.D. in experimental psychology, accepted an offer to run a secret pharmacology lab for Philip Morris Inc., maker of Marlboro and the world’s largest cigarette manufacturer.

DeNoble was to do research on nicotine’s effects on the behavior of rats. But the ultimate goal, he said, was the development of synthetic forms of nicotine that would give smokers a buzz while avoiding the chemical’s injurious effects on the heart.

Neither a smoker nor particular fan of the tobacco industry, DeNoble nonetheless said he was intrigued by the chance “to study a very mysterious drug” and make a contribution to society. There would always be millions of smokers, he believed, so it made sense to reduce their risk of cardiovascular disease–which kills more smokers than lung cancer.

But, within a few years, the tobacco wars invaded DeNoble’s cloister at the Philip Morris research center in Richmond, Va.

Like the other U.S. tobacco giants, Philip Morris suddenly found itself facing a wave of smoker-death claims. And as it girded for legal battle, DeNoble’s research loomed as a serious liability.

Read more: http://articles.latimes.com/1994-07-19/news/mn-17521_1_philip-morris
Print Print  

Like what we're doing? We'd appreciate your support.

Leave a comment